Epstein-barr Virus-associated Lymphoproliferative Disorder
📧 Sign up to get email alerts when something new happens for Epstein-barr Virus-associated Lymphoproliferative Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients
EVITA is a completed study monitoring Epstein-Barr virus infection in renal transplant recipients; the snippet does not include trial result…
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Application of PD-1 Inhibitors, Tenofovir, Chidamide, and Lenalidomide in Relapsed/Refractory EBV-associated Lymphoproliferative Disorders. [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial is evaluating a combination of PD-1 inhibitors, tenofovir, chidamide, and lenalidomide in relapsed or re…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas [Phase 2]
An open-label Phase 2 trial evaluating nanatinostat plus valganciclovir in EBV-positive relapsed/refractory lymphomas has been terminated, w…